Artia Global Partners’s AstraZeneca AZN Stock Holding History

Artia Global Partners’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.7M	Buy	98,376 +3,000	+3%	+$564K	3.44%	9
2026 Q1	$18.8M	Hold	95,376	–	–	3.77%	7
2025 Q4	$17.5M	Hold	95,376	–	–	2.48%	12
2025 Q3	$14.6M	Hold	95,376	–	–	2.32%	16
2025 Q2	$13.3M	Hold	95,376	–	–	3.21%	9
2025 Q1	$14M	Hold	95,376	–	–	3.55%	10
2024 Q4	$12.5M	Hold	95,376	–	–	4.47%	10
2024 Q3	$14.9M	Hold	95,376	–	–	4.05%	5
2024 Q2	$14.9M	Hold	95,376	–	–	2.88%	7
2024 Q1	$12.9M	Hold	95,376	–	–	2.6%	9
2023 Q4	$12.8M	Hold	95,376	–	–	3.74%	9
2023 Q3	$12.9M	Hold	95,376	–	–	5.37%	6
2023 Q2	$13.7M	Buy	95,376 +44,222	+86%	+$6.51M	4.71%	5
2023 Q1	$7.1M	Buy	51,154 +12,274	+32%	+$1.65M	2.62%	14
2022 Q4	$5.27M	Buy	+38,880	New	+$4.88M	2.01%	13

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Artia Global Partners's AZN Position: Q2 2026 in Review

Artia Global Partners increased its AstraZeneca (AZN) stake by 3.1% in Q2 2026, buying an estimated $564K and bringing the position to 98,376 shares worth $18.7M. The position accounts for 3.44% of the portfolio, ranked #9.

Artia Global Partners first reported a position in AZN in Q4 2022 and has held it in 15 quarters since. The position peaked at $18.8M in Q1 2026. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Artia Global Partners held 98,376 shares of AstraZeneca worth $18.7M as of Q2 2026.
Artia Global Partners bought 3,000 AstraZeneca shares in Q2 2026, an estimated $564K.
AstraZeneca made up 3.44% of Artia Global Partners's portfolio in Q2 2026, its #9 holding.
Artia Global Partners first reported a position in AstraZeneca in Q4 2022 and has held it in 15 quarters since.
Artia Global Partners's AstraZeneca position peaked at $18.8M in Q1 2026.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Artia Global Partners's 13F filing for Q2 2026, filed 14 Aug 2026.